Amneal Pharmaceuticals (AMRX) Cash from Operations Growth (5y) (2022 - 2026)
Amneal Pharmaceuticals (AMRX) Cash from Operations Growth (5y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.42 Bn | 87.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.86 Bn | 32.12 Bn | 1.97 Bn |
| 3 | Zoetis | 32.46 Bn | 30.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.52 Bn | 23.46 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.15 Bn | 20.99 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.17 Bn | 21.17 Bn | - |
| 7 | Viatris | 20.32 Bn | 18.51 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.74 Bn | 16.42 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.63 Bn | 12.20 Bn | 785.00 Mn |
| 10 | Amneal Pharmaceuticals | 5.68 Bn | 5.67 Bn | 320.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -16.87% |
| Dec 31, 2025 | 4.23% |
| Sep 30, 2025 | 21.48% |
| Jun 30, 2025 | -14.10% |
| Mar 31, 2025 | -31.47% |
| Dec 31, 2024 | 34.00% |
| Sep 30, 2024 | 0.27% |
| Jun 30, 2024 | 13.46% |
| Mar 31, 2024 | 47.29% |
| Dec 31, 2023 | -12.16% |
| Sep 30, 2023 | 5.55% |
| Jun 30, 2023 | 35.11% |
| Mar 31, 2023 | 38.89% |
| Sep 30, 2022 | 4.94% |